Suppr超能文献

尼索地平对人离体冠状动脉和静脉远段及近段内皮素-1诱发的收缩反应的影响。

Effect of nisoldipine on contractions evoked by endothelin-1 in human isolated distal and proximal coronary arteries and veins.

作者信息

Balligand J L, Godfraind T

机构信息

Laboratoire de Pharmacologie, Université Catholique de Louvain, Brussels, Belgium.

出版信息

J Cardiovasc Pharmacol. 1994 Oct;24(4):618-25. doi: 10.1097/00005344-199410000-00013.

Abstract

We investigated the differences in the vasoconstrictor effect of endothelin-1 (ET-1) on small and large human coronary arteries and veins and blockade of ET's action with calcium antagonists. Rings from distal and proximal human coronary arteries and veins were suspended in organ baths and exposed to graded concentrations of ET-1 (0.1-30 nM). Coronary veins were the most sensitive to the constrictor action of ET-1. In addition, distal coronary arteries were more sensitive than proximal arteries (EC50 value-log M: 8.92 +/- 0.05 and 8.34 +/- 0.1, respectively). In proximal arteries, incubation with subthreshold concentrations of ET (300 pM) potentiated the vasoconstrictor effect of serotonin 1 microM (115 +/- 2.6% over contractile level before incubation). This potentiated contraction was fully blocked by nisoldipine, a calcium antagonist. In contrast, this potentiation was not observed in human coronary veins. Nisoldipine partly antagonized the contraction evoked by ET-1 in human coronary arteries, but ET-contracted coronary veins were completely resistant to calcium channel blockade. Low concentrations of ET-1 approximating reported circulating levels result in significant contraction of human coronary veins and potentiate the constrictor effect of serotonin in coronary arteries. The blocking effect of the calcium antagonist nisoldipine varies among distal and proximal coronary arteries and veins, suggesting a different mechanism of contraction for ET-1 among these vessels. Because of the suspected role of ET-1 in coronary ischemic syndromes, this differential sensitivity may have important therapeutic implications.

摘要

我们研究了内皮素-1(ET-1)对人冠状动脉和静脉大小血管的血管收缩作用差异,以及钙拮抗剂对ET作用的阻断情况。将人冠状动脉和静脉远段及近段的血管环悬挂于器官浴槽中,暴露于不同浓度梯度的ET-1(0.1 - 30 nM)。冠状动脉静脉对ET-1的收缩作用最为敏感。此外,冠状动脉远段比近段更敏感(半数有效浓度值 - 对数M:分别为8.92±0.05和8.34±0.1)。在冠状动脉近段,用阈下浓度的ET(300 pM)孵育可增强血清素1 microM的血管收缩作用(较孵育前收缩水平增加115±2.6%)。这种增强的收缩作用可被钙拮抗剂尼索地平完全阻断。相比之下,在人冠状动脉静脉中未观察到这种增强作用。尼索地平可部分拮抗ET-1在人冠状动脉中引起的收缩,但ET收缩的冠状动脉静脉对钙通道阻断完全抵抗。低浓度的ET-1接近报道的循环水平时,可导致人冠状动脉静脉显著收缩,并增强血清素在冠状动脉中的收缩作用。钙拮抗剂尼索地平的阻断作用在冠状动脉远段和近段以及静脉之间存在差异,提示ET-1在这些血管中的收缩机制不同。由于怀疑ET-1在冠状动脉缺血综合征中的作用,这种差异敏感性可能具有重要的治疗意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验